Ji E Chang

Ji E Chang
Associate Professor of Public Health Policy and Management
-
Professional overview
-
Ji Eun Chang, Ph.D., is an Associate Professor in the Department of Public Health Policy and Management at the New York University School of Global Public Health, where she also serves as the public health policy and management concentration director for the Ph.D. program. Professor Chang uses mixed-methods research designs and draws from qualitative, quantitative, and geospatial data to demonstrate disparities and highlight barriers faced by safety net providers and underserved patients in accessing equitable care.
Professor Chang is the principal investigator of the AI4Healthy Cities Initiative in New York City, a multi-city collaboration between the Novartis Foundation, Microsoft AI4Health, and local health officials to reduce cardiovascular health inequities through big data analytics. Dr. Chang is also the co-principal investigator of an NIH NIDA-funded study to support implementing transitional opioid programs in safety net hospitals. Dr. Chang received a B.A. in Economics from the University of California at Berkeley, an M.S. in Public Policy and Management from Carnegie Mellon University, and a Ph.D. in Public Administration from New York University in 2016. -
Education
-
BA, Economics, University of California at Berkeley, Berkeley, CAMS, Public Policy and Management, Carnegie Mellon University, Pittsburgh, PAPhD, Public Administration, New York University, New York, NY
-
Honors and awards
-
Governor’s Scholar (2007)Regents and Chancellors’ Scholar (2005)
-
Areas of research and study
-
Cardiovascular DiseaseHealth DisparitiesHealth EquityPublic Health ManagementPublic Health ManagementSafety Net Providers and PatientsSubstance Use Disorders
-
Publications
Publications
Examining the Relationship between Local Governmental Expenditures on the Social Determinants of Health and County-Level Overdose Deaths, 2017-2020
Forging hospital and community partnerships to enable care coordination for opioid use disorder
Patient–Provider Communication for Lonely, Socially Isolated Adults in Medicare
Toward a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi Process
A Year After Implementation of the Telehealth Waiver: Being Offered and Utilizing Video-Specific Telehealth Among Dual-Eligible Medicare Recipients During the COVID-19 Pandemic
Barriers and Facilitators to Establishing Partnerships for Substance Use Disorder Care Transitions Between Safety-Net Hospitals and Community-Based Organizations
Comparing Rates of Undiagnosed Hypertension and Diabetes in Patients With and Without Substance Use Disorders
Discrimination in Medical Settings across Populations: Evidence From the All of Us Research Program
Examining the relationship between social determinants of health, measures of structural racism and county-level overdose deaths from 2017–2020
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals
Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services
The Ecology of Economic Distress and Life Expectancy
Trends in the availability of comprehensive services within outpatient substance use treatment facilities from 2018 to 2022
An observational, sequential analysis of the relationship between local economic distress and inequities in health outcomes, clinical care, health behaviors, and social determinants of health
Assessing Differences in Social Determinants of Health Screening Rates in a Large, Urban Safety-Net Health System
Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study
Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings
Facilitation of team-based care to improve HTN management and outcomes: a protocol for a randomized stepped wedge trial
Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing
Hospital adoption of harm reduction and risk education strategies to address substance use disorders
Integrating Harm Reduction into Medical Care: Lessons from Three Models
Rural-urban disparities in health outcomes, clinical care, health behaviors, and social determinants of health and an action-oriented, dynamic tool for visualizing them
Stakeholder Perspectives on Data-Driven Solutions to Address Cardiovascular Disease and Health Equity in New York City
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology
Substance Use Disorder Program Availability in Safety-Net and Non–Safety-Net Hospitals in the US